Author: digi

SOP for Implementing Stability Testing for High-Volume Manufacturing of Drug Products under Regulatory Guidelines

SOP for Implementing Stability Testing for High-Volume Manufacturing of Drug Products under Regulatory Guidelines Procedure for Stability Testing in High-Volume Drug Manufacturing 1) Purpose The purpose of this SOP is to outline the procedure for conducting stability testing for high-volume drug products in compliance with regulatory guidelines. This ensures that drug products maintain their quality,…

Stability Studies SOP

Aligning Equipment Deviations with Change Control and Stability Impact

In pharmaceutical manufacturing and stability programs, equipment deviations are inevitable. Whether due to calibration drift, equipment malfunction, or environmental excursions, such deviations can threaten the reliability of stability data. When not addressed promptly and systematically, they may lead to batch rejections, data invalidation, or even regulatory observations. Therefore, aligning deviation tracking with change control procedures…

Equipment and Calibration, Impact of Equipment Deviations on Stability Data

Role of Extractables and Leachables in Container Qualification

Extractables and leachables (E&L) play a pivotal role in determining the safety and suitability of pharmaceutical packaging. These studies help identify harmful substances that may migrate from the container closure system into the drug product during storage and use. Regulatory authorities such as the USFDA, EMA, and WHO mandate comprehensive E&L assessments to ensure packaging…

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

Ensure Interim Reports Are Clearly Labeled and Version-Controlled

Understanding the Tip: The role of interim reports in a stability program: Interim stability reports are often generated at key milestones to summarize time-point data for internal review, regulatory inquiries, or shelf life extensions. These reports are not final but serve as critical reference documents. If not clearly labeled and version-controlled, they can lead to…

Stability Study Tips

How to Perform Compatibility Testing for Container Materials

In pharmaceutical packaging, ensuring compatibility between the drug product and its container closure system is a critical step in guaranteeing safety, stability, and regulatory compliance. Compatibility testing helps identify any interaction that may affect the product’s identity, strength, quality, or purity over its shelf life. This guide outlines a comprehensive, step-by-step approach to conducting compatibility…

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

Deviation Tracking Systems in Pharma Stability Programs

In pharmaceutical stability programs, deviations—whether minor anomalies or major equipment failures—can significantly affect the validity of long-term data. Deviation tracking systems help maintain data integrity, support root cause investigations, and prepare organizations for regulatory inspections. In this tutorial, we’ll explore the importance of deviation tracking systems, their key features, and how they integrate into the…

Equipment and Calibration, Impact of Equipment Deviations on Stability Data

Reviewing Container Closure Systems in Regulatory Submissions

Container Closure Systems (CCS) are integral to pharmaceutical product integrity and must be adequately justified in regulatory submissions. Agencies such as the FDA, EMA, and CDSCO closely examine packaging sections within the Common Technical Document (CTD), especially Module 3. This article details how to prepare, structure, and present container closure data for stability studies in…

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

Case Studies: Packaging Failures in Real-World Stability Testing

In pharmaceutical manufacturing, packaging failures during stability testing can result in compromised product quality, regulatory citations, or delayed approvals. These failures often stem from overlooked container-closure risks, inadequate validation, or environmental stress. This article presents real-world case studies where packaging systems failed during stability and offers practical lessons to help you prevent similar outcomes. Case…

Packaging and Containers, Pharmaceutical Containers and Closures for Stability

SOP for Addressing Stability Testing for Drugs under Expedited Approval Pathways

SOP for Addressing Stability Testing for Drugs under Expedited Approval Pathways Procedure for Stability Testing of Drugs Under Expedited Approval Pathways 1) Purpose The purpose of this SOP is to define a procedure for conducting stability testing for drugs under expedited approval pathways, ensuring compliance with regulatory requirements while maintaining product quality, safety, and efficacy….

Stability Studies SOP

Avoid Retesting Without QA-Approved Justification in Stability Studies

Understanding the Tip: Why retesting stability samples needs strict control: Stability testing must reflect real-time degradation trends and provide a reliable basis for shelf life. Retesting without proper authorization can obscure true data, delay investigations, or result in selective reporting. Only when scientifically justified and QA-approved should a retest be allowed. This practice upholds the…

Stability Study Tips